8.51Open7.70Pre Close1 Volume78 Open Interest56.00Strike Price851.00Turnover103.55%IV-0.55%PremiumDec 20, 2024Expiry Date8.77Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9501Delta0.0225Gamma5.34Leverage Ratio-0.0545Theta-0.0036Rho-5.07Eff Leverage0.0047Vega
Viking Therapeutics Stock Discussion
loading...
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
No comment yet